Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Superficial”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Large-scale testing (Phase 3)Study completedNCT00330707
What this trial is testing

Combined Use of BCG and Interferon Alpha in Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
National University Hospital, Singapore 140
Large-scale testing (Phase 3)Study completedNCT00406068
What this trial is testing

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Neoplasms
Bioniche Life Sciences Inc. 129
Not applicableStudy completedNCT02002559
What this trial is testing

Narrow Band Imaging (NBI) Against Lugol for Squamous Esophageal Cancer

Who this might be right for
Superficial Esophageal Neoplasia
Chinese University of Hong Kong 180
Large-scale testing (Phase 3)Study completedNCT02773849
What this trial is testing

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Superficial Bladder Cancer
Ferring Pharmaceuticals 157
Not applicableStudy completedNCT02714504
What this trial is testing

Anti-mold Azole in the Prophylaxis for Invasive Fusariosis

Who this might be right for
FusariosisOnychomycosis
Universidade Federal do Rio de Janeiro 239
Testing effectiveness (Phase 2)Looking for participantsNCT04752722
What this trial is testing

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Who this might be right for
Superficial Bladder CancerNon-muscle Invasive Bladder Cancer With Carcinoma in SituNon-muscle Invasive Bladder Cancer
enGene, Inc. 350
Testing effectiveness (Phase 2)Study completedNCT01687244
What this trial is testing

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
FKD Therapies Oy 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07359807
What this trial is testing

A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.

Who this might be right for
Popliteal Artery DiseaseSuperficial Femoral Artery Disease
Concept Medical Inc. 478
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Not applicableStudy completedNCT03304834
What this trial is testing

Treatment of Insufficient Superficial and Perforating Veins of the Lower Limb Using HIFU

Who this might be right for
Varicose UlcerVeins DiseasesVein, Varicose
Theraclion 50
Testing effectiveness (Phase 2)Study completedNCT02281383
What this trial is testing

Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer

Who this might be right for
Bladder CancerHigh Risk Superficial
Memorial Sloan Kettering Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT03567655
What this trial is testing

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Asan Medical Center 41
Testing effectiveness (Phase 2)Study completedNCT00696579
What this trial is testing

Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
University Of Perugia 64
Early research (Phase 1)Study completedNCT03191578
What this trial is testing

Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®

Who this might be right for
High-Risk Non-Muscle-Invasive Bladder Cancer
Archivel Farma S.L. 44
Large-scale testing (Phase 3)Study completedNCT01442519
What this trial is testing

Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
University of Rome Tor Vergata 212
Early research (Phase 1)Study completedNCT02324582
What this trial is testing

MK-3475/BCG in High Risk Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
Southern Illinois University 18
Testing effectiveness (Phase 2)Study completedNCT04496219
What this trial is testing

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma In SituRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8+3 more
Fred Hutchinson Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT01939756
What this trial is testing

Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms

Who this might be right for
Superficial Bladder CancerLower Urinary Tract Symptoms
Savino M. Di Stasi 50
Not applicableStudy completedNCT04280679
What this trial is testing

Treatment of Insufficient Superficial and Perforatring Veins of the Lower Limb Using HIFU

Who this might be right for
Varicose VeinsVeins DiseasesVaricose Ulcer
Theraclion 22
Testing effectiveness (Phase 2)Study completedNCT00141531
What this trial is testing

Phase II Trial of EOquin in High-risk Superficial Bladder Cancer

Who this might be right for
Bladder Neoplasms
Spectrum Pharmaceuticals, Inc 53
Next Page